CTLA4 and temporal arteritis: Although certain differences, such as the trend toward lower CTLA‐4 serum concentrations in patients with PMR with concomitant GCA compared with isolated PMR, may be biologically plausible given the immunoregulatory role of CTLA‐4, their clinical relevance remains uncertain.